{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:30:05Z","timestamp":1783031405507,"version":"3.54.6"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T00:00:00Z","timestamp":1604102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T00:00:00Z","timestamp":1604102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 824 A10"],"award-info":[{"award-number":["SFB 824 A10"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 824 Z2"],"award-info":[{"award-number":["SFB 824 Z2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Projekt DEAL"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>As a major activator of transforming growth factor \u03b2 (TGF-\u03b2), the RGD receptor \u03b1v\u03b28-integrin is involved in pathogenic processes related to TGF-\u03b2 dysregulation, such as tumor growth, invasion, and radiochemoresistance, metastasis and tumor cell stemness, as well as epithelial-mesenchymal transition. The novel positron emission tomography (PET) radiopharmaceutical Ga-68-Triveoctin for in vivo mapping of \u03b1v\u03b28-integrin expression might enhance the prognosis of certain tumor entities, as well as support and augment TGF-\u03b2-targeted therapeutic approaches.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Monomeric and trimeric conjugates of cyclo(GLRGDLp(<jats:italic>N<\/jats:italic>Me)K(pent-4-ynoic amide)) were synthesized by click chemistry (CuAAC), labeled with Ga-68, and evaluated in MeWo (human melanoma) xenografted SCID mice by means of PET and ex-vivo biodistribution. \u03b1v\u03b28-integrin expression in murine tissues was determined by \u03b28-IHC. A human subject received a single injection of 173\u00a0MBq of Ga-68-Triveoctin and underwent 3 subsequent PET\/CT scans at 25, 45, and 90\u00a0min p.i..<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The trimer Ga-68-Triveoctin exhibits a 6.7-fold higher \u03b1v\u03b28-integrin affinity than the monomer (IC<jats:sub>50<\/jats:sub>of 5.7 vs. 38\u00a0nM, respectively). Accordingly, biodistribution showed a higher tumor uptake (1.9 vs. 1.0%IA\/g, respectively) but a similar baseline upon blockade (0.25%IA\/g for both). IHC showed an intermediate \u03b28-expression in the tumor while most organs and tissues were found \u03b28-negative. Low non-target tissue uptakes (&lt;\u20090.4%IA\/g) confirmed a low degree of unspecific binding. Due to its hydrophilicity (log<jats:italic>D<\/jats:italic>\u2009=\u2009\u2212\u20093.1), Ga-68-Triveoctin is excreted renally and shows favorable tumor\/tissue ratios in mice (t\/blood: 6.7; t\/liver: 6.8; t\/muscle: 29). A high kidney uptake in mice (kidney-to-blood and -to-muscle ratios of 126 and 505, respectively) is not reflected by human PET (corresponding values are 15 and 30, respectively), which furthermore showed notable uptakes in coeliac and choroid plexus (SUVmean 6.1 and 9.7, respectively, 90\u00a0min p.i.).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Ga-68-Triveoctin enables sensitive in-vivo imaging \u03b1v\u03b28-integrin expression in murine tumor xenografts. PET in a human subject confirmed a favorable biodistribution, underscoring the potential of Ga-68-Triveoctin for mapping of \u03b1v\u03b28-integrin expression in a clinical setting.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13550-020-00706-1","type":"journal-article","created":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T13:03:13Z","timestamp":1604149393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Tracking a TGF-\u03b2 activator in vivo: sensitive PET imaging of \u03b1v\u03b28-integrin with the Ga-68-labeled cyclic RGD octapeptide trimer Ga-68-Triveoctin"],"prefix":"10.1186","volume":"10","author":[{"given":"Neil Gerard","family":"Quigley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Steiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frauke","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilko","family":"Weichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Hober\u00fcck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Kotzerke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3964-3391","authenticated-orcid":false,"given":"Johannes","family":"Notni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,31]]},"reference":[{"key":"706_CR1","doi-asserted-by":"crossref","first-page":"19650","DOI":"10.1016\/S0021-9258(18)55042-0","volume":"266","author":"M Moyle","year":"1991","unstructured":"Moyle M, Napier MA, McLean JW. Cloning and expression of a divergent integrin subunit \u03b28. J Biol Chem. 1991;266:19650\u20138.","journal-title":"J Biol Chem"},{"key":"706_CR2","doi-asserted-by":"crossref","first-page":"28708","DOI":"10.1016\/S0021-9258(19)61963-0","volume":"269","author":"SL Nishimura","year":"1994","unstructured":"Nishimura SL, Sheppard D, Pytela R. Integrin \u03b1v\u03b28. J Biol Chem. 1994;269:28708\u201315.","journal-title":"J Biol Chem"},{"key":"706_CR3","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJM200005043421807","volume":"34","author":"GC Blobe","year":"2000","unstructured":"Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor \u03b2 in human disease. N Engl J Med. 2000;34:1350\u20138.","journal-title":"N Engl J Med"},{"key":"706_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.tibs.2010.08.002","volume":"36","author":"JJ Worthington","year":"2011","unstructured":"Worthington JJ, Klementowicz JE, Travis MA. TGF-\u03b2: a sleeping giant awoken by integrins. Trends Biochem Sci. 2011;36:47\u201354.","journal-title":"Trends Biochem Sci"},{"key":"706_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00441-016-2474-y","volume":"365","author":"Z Khan","year":"2016","unstructured":"Khan Z, Marshall JF. Thr role of integrins in TGF-\u03b2 activation in the tumour stroma. Cell Tissue Res. 2016;365:657\u201373.","journal-title":"Cell Tissue Res"},{"key":"706_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nature21119","volume":"542","author":"T Ha","year":"2017","unstructured":"Ha T. Growth factor rattled out of its cage. Nature. 2017;542:40\u20131.","journal-title":"Nature"},{"key":"706_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature21035","volume":"542","author":"X Dong","year":"2017","unstructured":"Dong X, Zhao B, Iacob RE, Zhu J, Koksal AC, Lu C, Engen JR, Springer TA. Force interacts with macromolecular structure in activation of TGF-\u03b2. Nature. 2017;542:55\u20139.","journal-title":"Nature"},{"key":"706_CR8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1083\/jcb.200109100","volume":"157","author":"D Mu","year":"2002","unstructured":"Mu D, Cambier S, Fjellbirkeland L, Baron JL, Munger JS, Kawakatsu H, Sheppard D, Broaddus VC, Nishimura SL. The integrin \u03b1v\u03b28 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-\u03b2. J Cell Biol. 2002;157:493\u2013507.","journal-title":"J Cell Biol"},{"key":"706_CR9","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3390\/cancers11091221","volume":"11","author":"NF Brown","year":"2019","unstructured":"Brown NF, Marshall JF. Integrin-mediated TGF-\u03b2 activation modulates the tumour microenvironment. Cancers. 2019;11:1221.","journal-title":"Cancers"},{"key":"706_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.gde.2010.12.004","volume":"21","author":"GJ Inman","year":"2011","unstructured":"Inman GJ. Switching TGF-\u03b2 from a tumor suppressor to a tumor promoter. Curr Opin Genet Dev. 2011;21:93\u20139.","journal-title":"Curr Opin Genet Dev"},{"key":"706_CR11","first-page":"7084","volume":"60","author":"S Cambier","year":"2000","unstructured":"Cambier S, Mu DZ, O\u2019Connell D, Boylen K, Travis W, Liu WH, Broaddus VC, Nishimura SL. A role for the integrin \u03b1v\u03b28 in the negative regulation of epithelial cell growth. Cancer Res. 2000;60:7084\u201393.","journal-title":"Cancer Res"},{"key":"706_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cell.2009.01.039","volume":"137","author":"M Adorno","year":"2009","unstructured":"Adorno M, Cordenonsi M, Montagner M, Dupont S, Wong C, Hann B, Solari A, Bobisse S, Rondina MB, Guzzardo V, et al. A Mutant-p53\/Smad complex opposes p63 to empower TGF-\u03b2-induced metastasis. Cell. 2009;137:87\u201398.","journal-title":"Cell"},{"key":"706_CR13","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1053\/j.gastro.2009.11.004","volume":"138","author":"B Zhang","year":"2010","unstructured":"Zhang B, Halder SK, Kashikar ND, Cho YJ, Datta A, Gorden DL, Datta PK. Antimetastatic role of Smad4 signaling in colorectal cancer. Gastroenterology. 2010;138:969\u201380.","journal-title":"Gastroenterology"},{"key":"706_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00441-017-2633-9","volume":"320","author":"M Villalba","year":"2017","unstructured":"Villalba M, Evans SR, Vidal-Vanaclocha F, Calvo A. Role of TGF-\u03b2 in metastatic colon cancer: it is finally time for targeted therapy. Cell Tissue Res. 2017;320:29\u201339.","journal-title":"Cell Tissue Res"},{"key":"706_CR15","doi-asserted-by":"publisher","first-page":"6568","DOI":"10.1038\/onc.2017.248","volume":"47","author":"PA Guerrero","year":"2017","unstructured":"Guerrero PA, Tchaicha JH, Chen Z, Morales JE, McCarty N, Wang Q, Sulman EP, Fuller G, Lang FF, Rao G, McCarty JH. Glioblastoma stem cells exploit the \u03b1v\u03b28 integrin-TGF\u03b21 signaling axis to drive tumor initiation and progression. Oncogene. 2017;47:6568\u201380.","journal-title":"Oncogene"},{"key":"706_CR16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12885-015-1164-6","volume":"15","author":"I Mertens-Walker","year":"2015","unstructured":"Mertens-Walker I, Fernandini BC, Maharaj MSN, Rockstroh A, Nelson CC, Herington AC, Stephenson SA. The tumour-promoting receptor tyrosine kinase, EphB4, regulates expression of Integrin-\u03b28 in prostate cancer cells. BMC Cancer. 2015;15:164.","journal-title":"BMC Cancer"},{"key":"706_CR17","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/S0002-9440(10)62497-2","volume":"166","author":"S Cambier","year":"2005","unstructured":"Cambier S, Gline S, Mu D, Collins R, Araya J, Dolganov G, Einheber S, Boudreau N, Nishimura SL. Integrin \u03b1v\u03b28-mediated activation of transforming growth factor-\u03b2 by perivascular astrocytes. Am J Pathol. 2005;166:1883\u201394.","journal-title":"Am J Pathol"},{"key":"706_CR18","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1091\/mbc.e12-07-0521","volume":"24","author":"SB Reyes","year":"2013","unstructured":"Reyes SB, Narayanan AS, Lee HS, Tchaicha JH, Aldape KD, Lang FF, Tolias KF, McCarty JH. \u03b1v\u03b28 integrin interacts with RhoGDI1 to regulate Rac1 and Cdc42 activation and drive glioblastoma cell invasion. Mol Biol Cell. 2013;24:474\u201382.","journal-title":"Mol Biol Cell"},{"key":"706_CR19","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1021\/acs.jmedchem.8b01588","volume":"62","author":"F Reichart","year":"2019","unstructured":"Reichart F, Maltsev OV, Kapp TG, R\u00e4der AFB, Weinm\u00fcller M, Marelli UK, Notni J, Wurzer A, Beck R, Wester HJ, Steiger K, Di Maro S, Di Leva FS, Marinelli L, Nieberler M, Reuning U, Schwaiger M, Kessler H. Selective targeting of integrin \u03b1v\u03b28 by a highly active cyclic peptide. J Med Chem. 2019;62:2024\u201337.","journal-title":"J Med Chem"},{"key":"706_CR20","doi-asserted-by":"publisher","first-page":"39805","DOI":"10.1038\/srep39805","volume":"7","author":"TG Kapp","year":"2017","unstructured":"Kapp TG, Rechenmacher F, Neubauer S, Maltsev O, Cavalcanti-Adam AE, Zarka R, Reuning U, Notni J, Wester HJ, Mas-Moruno C, Spatz J, Geiger B, Kessler H. A comprehensive evaluation of the activity and selectivity profile of ligands for RGD-binding integrins. Sci Rep. 2017;7:39805.","journal-title":"Sci Rep"},{"key":"706_CR21","doi-asserted-by":"publisher","first-page":"14718","DOI":"10.1002\/chem.201103503","volume":"17","author":"J Notni","year":"2011","unstructured":"Notni J, \u0160ime\u010dek J, Hermann P, Wester HJ. TRAP, a powerful and versatile framework for gallium-68 radiopharmaceuticals. Chemistry. 2011;17:14718\u201322.","journal-title":"Chemistry"},{"key":"706_CR22","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1021\/acsomega.8b00035","volume":"3","author":"SF F\u00e4rber","year":"2018","unstructured":"F\u00e4rber SF, Wurzer A, Reichart F, Beck R, Kessler H, Wester HJ, Notni J. Therapeutic radiopharmaceuticals targeting integrin \u03b1v\u03b26. ACS Omega. 2018;3:2428\u201336.","journal-title":"ACS Omega"},{"key":"706_CR23","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.nucmedbio.2012.02.006","volume":"39","author":"K Pohle","year":"2012","unstructured":"Pohle K, Notni J, Bussemer J, Kessler H, Schwaiger M, Beer AJ. 68Ga-NODAGA-RGD is a suitable substitute for 18F-Galacto-RGD and can be produced with high specific activity in a cGMP\/GRP compliant automated process. Nucl Med Biol. 2012;39:777\u201384.","journal-title":"Nucl Med Biol"},{"key":"706_CR24","first-page":"1023","volume":"46","author":"MG Stabin","year":"2005","unstructured":"Stabin MG, Sparks RB, Crowe E. OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023\u20137.","journal-title":"J Nucl Med"},{"key":"706_CR25","doi-asserted-by":"publisher","first-page":"11137","DOI":"10.1039\/C5DT00576K","volume":"44","author":"Z Baranyai","year":"2015","unstructured":"Baranyai Z, Reich D, V\u00e1gner A, et al. A shortcut to high-affinity Ga-68 and Cu-64 radiopharmaceuticals: one-pot click chemistry trimerisation on the TRAP platform. Dalton Trans. 2015;44:11137\u201346.","journal-title":"Dalton Trans"},{"key":"706_CR26","doi-asserted-by":"publisher","first-page":"671","DOI":"10.2967\/jnumed.116.182824","volume":"58","author":"J Notni","year":"2017","unstructured":"Notni J, Reich D, Maltsev OV, Kapp TG, Steiger K, Hoffmann F, Esposito I, Weichert W, Kessler H, Wester HJ. In vivo PET imaging of the cancer integrin \u03b1v\u03b26 using 68Ga-labeled cyclic RGD nonapeptides. J Nucl Med. 2017;58:671\u20137.","journal-title":"J Nucl Med"},{"key":"706_CR27","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1021\/acs.molpharmaceut.8b00602","volume":"15","author":"A Wurzer","year":"2018","unstructured":"Wurzer A, Pollmann J, Schmidt A, Reich D, Wester HJ, Notni J. Molar activity of Ga-68 labeled PSMA inhibitor conjugates determines PET imaging results. Mol Pharmaceutics. 2018;15:4296\u2013302.","journal-title":"Mol Pharmaceutics"},{"key":"706_CR28","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1002\/cmdc.201400055","volume":"9","author":"J Notni","year":"2014","unstructured":"Notni J, \u0160ime\u010dek J, Wester HJ. Phosphinic acid functionalized polyazacycloalkane chelators for radiodiagnostics and radiotherapeutics: unique characteristics and applications. ChemMedChem. 2014;9:1107\u201315.","journal-title":"ChemMedChem"},{"key":"706_CR29","doi-asserted-by":"publisher","first-page":"7174","DOI":"10.1002\/chem.200903281","volume":"16","author":"J Notni","year":"2010","unstructured":"Notni J, Hermann P, Havl\u00ed\u010dkov\u00e1 J, et al. A triazacyclononane-based bifunctional phosphinate ligand for the preparation of multimeric 68Ga tracers for positron emission tomography. Chem Eur J. 2010;16:7174\u201385.","journal-title":"Chem Eur J"},{"key":"706_CR30","doi-asserted-by":"publisher","first-page":"11500","DOI":"10.1002\/chem.201600928","volume":"22","author":"J Notni","year":"2016","unstructured":"Notni J, Wester HJ. A practical guide on the synthesis of metal chelates for molecular imaging and therapy by means of click chemistry. Chem Eur J. 2016;22:11500\u20138.","journal-title":"Chem Eur J"},{"key":"706_CR31","doi-asserted-by":"publisher","first-page":"5157","DOI":"10.1242\/dev.069153","volume":"138","author":"S Hirota","year":"2011","unstructured":"Hirota S, Liu Q, Lee HS, Hossain MG, Lacy-Hulbert A, McCarty JH. The astrocyte-expressed integrin \u03b1v\u03b28 governs blood vessel sprouting in the developing retina. Development. 2011;138:5157\u201366.","journal-title":"Development"},{"key":"706_CR32","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ajpath.2010.10.031","volume":"178","author":"S Khan","year":"2011","unstructured":"Khan S, Lakhe-Reddy S, McCarty JH, Sorenson CM, Sheibani N, Reichardt LF, Kim JH, Wang B, Sedor JR, Schelling JR. Mesangial cell integrin \u03b1v\u03b28 provides glomerular endothelial cell cytoprotection by sequestering TGF-\u03b2 and regulating PECAM-1. Am J Pathol. 2011;178:609\u201320.","journal-title":"Am J Pathol"},{"key":"706_CR33","doi-asserted-by":"publisher","first-page":"F1400","DOI":"10.1152\/ajprenal.00624.2013","volume":"306","author":"S Lakhe-Reddy","year":"2014","unstructured":"Lakhe-Reddy S, Li V, Arnold TD, Khan S, Schelling JR. Mesangial cell \u03b1v\u03b28 -integrin regulates glomerular capillary integrity and repair. Am J Physiol Renal Physiol. 2014;306:F1400\u20139.","journal-title":"Am J Physiol Renal Physiol"},{"key":"706_CR34","doi-asserted-by":"publisher","first-page":"7748","DOI":"10.1002\/chem.201300338","volume":"19","author":"J \u0160ime\u010dek","year":"2013","unstructured":"\u0160ime\u010dek J, Hermann P, Havl\u00ed\u010dkov\u00e1 J, et al. A cyclen-based tetraphosphinate chelator for preparation of radiolabeled tetrameric bioconjugates. Chemistry. 2013;19:7748\u201357.","journal-title":"Chemistry"},{"key":"706_CR35","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1002\/chem.200204304","volume":"9","author":"G Thumshirn","year":"2003","unstructured":"Thumshirn G, Hersel U, Goodman SL, Kessler H. Multimeric cyclic RGD peptides as potential tools for tumor targeting: solid-phase peptide synthesis and chemoselective oxime ligation. Chemistry. 2003;9:2717\u201325.","journal-title":"Chemistry"},{"key":"706_CR36","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00259-006-0180-9","volume":"34","author":"I Dijkgraaf","year":"2007","unstructured":"Dijkgraaf I, Kruijtzer JAW, Liu S, et al. Improved targeting of the \u03b1v\u03b23 integrin by multimerisation of RGD peptides. Eur J Nucl Med Mol Imaging. 2007;34:267\u201373.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"706_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cbic.201000386","volume":"11","author":"C W\u00e4ngler","year":"2010","unstructured":"W\u00e4ngler C, Maschauer S, Prante O, et al. Multimerization of cRGD peptides by click chemistry: synthetic strategies, chemical limitations, and influence on biological properties. ChemBioChem. 2010;11:1\u201315.","journal-title":"ChemBioChem"},{"key":"706_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nucmedbio.2019.09.002","volume":"78\u201379","author":"P Kaeopookum","year":"2019","unstructured":"Kaeopookum P, Petrik M, Summer D, Klinger M, Zhai C, Rangger C, Haubner R, Haas H, Hajduch M, Decristoforo C. Comparison of 68Ga-labeled RGD mono- and multimers based on a clickable siderophore-based scaffold. Nucl Med Biol. 2019;78\u201379:1\u201310.","journal-title":"Nucl Med Biol"},{"key":"706_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202000200","author":"NG Quigley","year":"2020","unstructured":"Quigley NG, Tomassi S, Di Leva FS, Di Maro S, Richter F, Steiger K, Kossatz S, Marinelli L, Notni J. Click-chemistry (CuAAC) trimerization of an \u03b1v\u03b26-integrin targeting Ga-68-peptide: enhanced contrast for in-vivo PET imaging of human lung adenocarcinoma xenografts. ChemBioChem. 2020. https:\/\/doi.org\/10.1002\/cbic.202000200 .","journal-title":"ChemBioChem"},{"key":"706_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/ph10010029","volume":"10","author":"S Maschauer","year":"2017","unstructured":"Maschauer S, Einsiedel J, Reich D, H\u00fcbner H, Gmeiner P, Wester HJ, Prante O, Notni J. Theranostic value of multimers: lessons learned from trimerization of neurotensin receptor ligands and other targeting vectors. Pharmaceuticals. 2017;10:29.","journal-title":"Pharmaceuticals"},{"key":"706_CR41","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1021\/mp5000746","volume":"11","author":"J \u0160ime\u010dek","year":"2014","unstructured":"\u0160ime\u010dek J, Notni J, Kapp TG, Kessler H, Wester HJ. Benefits of NOPO as chelator in gallium-68 peptides, exemplified by preclinical characterization of 68Ga-NOPO-c(RGDfK). Mol Pharm. 2014;11:1687\u201395.","journal-title":"Mol Pharm"},{"key":"706_CR42","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fchem.2018.00170","volume":"6","author":"A V\u00e1gner","year":"2018","unstructured":"V\u00e1gner A, Forg\u00e1cs A, Br\u00fccher E, T\u00f3th I, Maiocchi A, Wurzer A, Wester HJ, Notni J, Baranyai Z. Equilibrium thermodynamics, formation, and dissociation kinetics of trivalent iron and gallium complexes of triazacyclononane-triphosphinate (TRAP) chelators: unraveling the foundations of highly selective Ga-68 labeling. Front Chem. 2018;6:170.","journal-title":"Front Chem"},{"key":"706_CR43","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/cmdc.201200471","volume":"8","author":"J \u0160ime\u010dek","year":"2013","unstructured":"\u0160ime\u010dek J, Hermann P, Wester HJ, Notni J. How is 68Ga-labeling of macrocyclic chelators influenced by metal ion contaminants in 68Ge\/68Ga generator eluates? ChemMedChem. 2013;8:95\u2013103.","journal-title":"ChemMedChem"},{"key":"706_CR44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/2191-219X-2-28","volume":"2","author":"J Notni","year":"2012","unstructured":"Notni J, Pohle K, Wester HJ. Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-peptides: practical consequences for the future of gallium-68-PET. EJNMMI Res. 2012;2:28.","journal-title":"EJNMMI Res"},{"key":"706_CR45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/jlcr.3582","volume":"61","author":"J Notni","year":"2018","unstructured":"Notni J, Wester HJ. Re-thinking the role of radiometal isotopes: Towards a future concept for theranostic radiopharmaceuticals. J Label Compd Radiopharm. 2018;61:141\u201353.","journal-title":"J Label Compd Radiopharm"},{"key":"706_CR46","doi-asserted-by":"publisher","first-page":"e122591","DOI":"10.1172\/jci.insight.122591","volume":"3","author":"N Takasaka","year":"2018","unstructured":"Takasaka N, Seed RI, Cormier A, Bondesson AJ, Lou J, Elattma A, Ito S, Yanagisawa H, Hashimoto M, Ma R, Levine MD, Publicover J, Potts R, Jespersen JM, Campbell MG, Conrad F, Marks JD, Cheng Y, Baron JL, Nishimura SL. Integrin \u03b1v\u03b28-expressing tumor cells evade host immunity by regulating TGF-\u03b2 activation in immune cells. JCI Insight. 2018;3:e122591.","journal-title":"JCI Insight"},{"key":"706_CR47","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1016\/j.drudis.2019.08.011","volume":"24","author":"L Rotteveel","year":"2019","unstructured":"Rotteveel L, Poot AJ, Bogaard HJ, ten Dijke P, Lammertsma AA, Windhorst AD. In vivo imaging of TGF signalling components using positron emission tomography. Drug Discov Today. 2019;24:2258\u201372.","journal-title":"Drug Discov Today"},{"key":"706_CR48","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.ejca.2010.02.040","volume":"46","author":"M Korpal","year":"2010","unstructured":"Korpal M, Kang Y. Targeting the transforming growth factor \u03b2 signalling pathway in metastatic cancer. Eur J Cancer. 2010;46:1232\u201340.","journal-title":"Eur J Cancer"},{"key":"706_CR49","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1177\/0192623311416259","volume":"39","author":"MJ Anderton","year":"2011","unstructured":"Anderton MJ, Mellor HR, Bell A, Sadler C, Pass M, Powell S, Steele SJ, Roberts RR, Heier A. Induction of heart valve lesions by small-molecule ALK5 inhibitors. Toxicol Pathol. 2011;39:916\u201324.","journal-title":"Toxicol Pathol"},{"key":"706_CR50","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.2353\/ajpath.2009.080723","volume":"174","author":"A Vitsky","year":"2009","unstructured":"Vitsky A, Waire J, Pawliuk R, Bond A, Matthews D, Lacasse E, Hawes ML, Nelson C, Richards S, Piepenhagen PA, Garman RD, Andrews L, Thurberg BL, Lonning S, Ledbetter S, Ruzek MC. Homeostatic role of transforming growth factor-beta in the oral cavity and esophagus of mice and its expression by mast cells in these tissues. Am J Pathol. 2009;174:2137\u201349.","journal-title":"Am J Pathol"},{"key":"706_CR51","first-page":"3063","volume":"8","author":"WW Wang","year":"2015","unstructured":"Wang WW, Wang YB, Wang DQ, Lin Z, Sun RJ. Integrin \u03b2-8 (ITGB8) silencing reverses gefitinib resistance of human hepatic cancer HepG2\/G cell line. Int J Clin Exp Med. 2015;8:3063\u201371.","journal-title":"Int J Clin Exp Med"},{"key":"706_CR52","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1158\/1541-7786.MCR-18-1352","volume":"17","author":"S Jin","year":"2019","unstructured":"Jin S, Lee WC, Aust D, Pilarsky C, Cordes N. \u03b28 integrin mediates pancreatic cancer cell radiochemoresistance. Mol Cancer Res. 2019;17:2126\u201338.","journal-title":"Mol Cancer Res"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-020-00706-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13550-020-00706-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-020-00706-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,11]],"date-time":"2021-04-11T15:21:05Z","timestamp":1618154465000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-020-00706-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,31]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["706"],"URL":"https:\/\/doi.org\/10.1186\/s13550-020-00706-1","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,31]]},"assertion":[{"value":"16 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Procedures involving laboratory mice and their care were conducted in conformity with institutional guidelines and with approval from the responsible local authorities (Regierung von Oberbayern, ROB-55.2-2532.Vet_2-18-109). The authors affirm that the patient provided written informed consent prior to the investigation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors affirm that the patient provided written informed consent for publication of the images and data in Fig.\u00a0and Tablesand, respectively.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"133"}}